It’s March 2020. The Coronavirus bursts onto the scene. Overnight, whole countries are locked down. Shops are shuttered. Offices close. Flights stop. The streets are empty. GPs close their practices. Hospitals batten down the hatches to focus on Covid and emergency care.
Leading the field in diagnostics for over 30 years has required us to adapt quickly to the changing needs of our customers. At Unilabs, we pride ourselves on being a lean organisation where everybody – whatever their seniority – rolls up their sleeves to get things done.
Unilabs, a leading international provider of diagnostic services, and Ibex Medical Analytics, the pioneer in artificial intelligence-powered cancer diagnostics, have agreed a deal to implement Ibex’ AI platform in Europe.
Swiss watches have a worldwide reputation. Switzerland has a distinguished history of horological innovation and excellence – boasting the most exquisite craftsmanship and a philosophy of continuous refinement.
Imaging, a cornerstone of modern health care, is a rapidly evolving field. At Unilabs, we are part of this exciting journey – developing and evaluating new imaging techniques and innovations. Lately, AI has become an ever more promising tool to enhance medical imaging. The research community is working feverishly on how to take advantage of the possibilities of AI in the clinic. The goal is to provide modern, accurate diagnostics to our patients. And Unilabs is at the forefront of this evolution.
Unilabs, the leading European diagnostic group, has opened a large-scale vaccination drive-through at the Queimódromo in Porto, Portugal, in partnership with ARS-Norte, Câmara Municipal do Porto, Hospital de São João, and Centro Hospitalar do Porto.
Faithful to its goal to be as creative, inventive, caring, and purpose-driven as the people who work there, TMC - Unilabs’ teleradiology arm – has sponsored the second report by the British Institute of Radiology and the BIR World Partner Network.
Geneva, 29 June 2021: Unilabs, the leading European diagnostic services provider, has created a new PCR test that can specifically identify the new, more infectious Delta variant, and is working with health authorities to optimise public health measures accordingly.
Questo sito utilizza cookie per migliorare l'esperienza di navigazione degli utenti. Proseguendo nella navigazione si accetta l’uso dei cookie. Per ulteriori informazioni e/o per impedire l'uso di cookie durante l'accesso al sito, visita la nostra pagina Data Protection.